Table 4

Event rates per 100 person-years for appropriate ICD therapy in the cohort overall and the below- vs. above-median inactive duration, peak cadence, and sleep duration groups

Overall cohort (95% CI)Inactive duration (95% CI)Peak cadence (95% CI)Total sleep duration (95% CI)
BelowAboveP-valueaBelowAboveP-valueaBelowAboveP-valuea
Event rates per 100 person-years19.13 [13.66–26.05]17.0 [10.1–26.8]21.4 [13.4–32.3]0.799.0 [4.3–16.6]30.6 [20.6–43.6]<0.00112.9 [7.0–21.6]25.9 [16.9–38.0]0.045
Overall cohort (95% CI)Inactive duration (95% CI)Peak cadence (95% CI)Total sleep duration (95% CI)
BelowAboveP-valueaBelowAboveP-valueaBelowAboveP-valuea
Event rates per 100 person-years19.13 [13.66–26.05]17.0 [10.1–26.8]21.4 [13.4–32.3]0.799.0 [4.3–16.6]30.6 [20.6–43.6]<0.00112.9 [7.0–21.6]25.9 [16.9–38.0]0.045

CRT-D, cardiac resynchronization therapy; ICD, implantable cardioverter defibrillator; CI, confidence interval.

aCox proportional hazard models adjusted for age, sex, heart failure diagnosis, ischaemic heart disease, device type (CRT-D vs. ICD), and prevention type (primary vs. secondary).

Table 4

Event rates per 100 person-years for appropriate ICD therapy in the cohort overall and the below- vs. above-median inactive duration, peak cadence, and sleep duration groups

Overall cohort (95% CI)Inactive duration (95% CI)Peak cadence (95% CI)Total sleep duration (95% CI)
BelowAboveP-valueaBelowAboveP-valueaBelowAboveP-valuea
Event rates per 100 person-years19.13 [13.66–26.05]17.0 [10.1–26.8]21.4 [13.4–32.3]0.799.0 [4.3–16.6]30.6 [20.6–43.6]<0.00112.9 [7.0–21.6]25.9 [16.9–38.0]0.045
Overall cohort (95% CI)Inactive duration (95% CI)Peak cadence (95% CI)Total sleep duration (95% CI)
BelowAboveP-valueaBelowAboveP-valueaBelowAboveP-valuea
Event rates per 100 person-years19.13 [13.66–26.05]17.0 [10.1–26.8]21.4 [13.4–32.3]0.799.0 [4.3–16.6]30.6 [20.6–43.6]<0.00112.9 [7.0–21.6]25.9 [16.9–38.0]0.045

CRT-D, cardiac resynchronization therapy; ICD, implantable cardioverter defibrillator; CI, confidence interval.

aCox proportional hazard models adjusted for age, sex, heart failure diagnosis, ischaemic heart disease, device type (CRT-D vs. ICD), and prevention type (primary vs. secondary).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close